| 000 | 01078 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512212242.0 | ||
| 264 | 0 | _c19841228 | |
| 008 | 198412s 0 0 eng d | ||
| 022 | _a0305-7372 | ||
| 024 | 7 |
_a10.1016/0305-7372(84)90001-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarter, S K | |
| 245 | 0 | 0 |
_aAnticancer drug development--a challenge for industry and government. _h[electronic resource] |
| 260 |
_bCancer treatment reviews _cJun 1984 |
||
| 300 |
_a87-101 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xstandards |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndustry |
| 650 | 0 | 4 | _aNational Institutes of Health (U.S.) |
| 650 | 0 | 4 | _aResearch |
| 650 | 0 | 4 | _aResearch Support as Topic |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aStringfellow, D | |
| 773 | 0 |
_tCancer treatment reviews _gvol. 11 _gno. 2 _gp. 87-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0305-7372(84)90001-x _zAvailable from publisher's website |
| 999 |
_c6388735 _d6388735 |
||